De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy

International Journal of Hematology

Volumn 99, Issue 2, 2014, Pages 184-187

  Strmecki, Lana ^a,b   Hudler, Petra ^b   Benedik Dolničar, Majda ^c   Komel, Radovan ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

DMD; Duchenne muscular dystrophy; Factor VIII; Hemophilia; X linked diseases

Indexed keywords

ADULT; DYSTROPHIN; FACTOR VIII; GENE DELETION; HEMOPHILIA A; HUMANS; INTRONS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; SEQUENCE INVERSION; SEVERITY OF ILLNESS INDEX;

EID: 84894442300     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1488-4     Document Type: Article

References (14)

1. Rossetti LC, Radic CP, Abelleyro MM, Larripa IB, De Brasi CD. Eighteen years of molecular genotyping the hemophilia inversion hotspot: from southern blot to inverse shifting-PCR. Int J Mol Sci. 2011;12:7271-85.
2. Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, et al. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood. 1995;86:2206-12.
3. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993;5:236-41.
4. del Gaudio D, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, et al. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat. 2008;29:1100-7.
5. Oshima J, Magner DB, Lee JA, Breman AM, Schmitt ES, White LD, et al. Regional genomic instability predisposes to complex dystrophin gene rearrangements. Hum Genet. 2009;126:411-23.
6. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002;82:291-329.
7. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45-8.
8. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;16:11141-56.
9. Zhang AH, Skupsky J, Scott DW. Factor VIII inhibitors: risk factors and methods for prevention and immune modulation. Clin Rev Allergy Immunol. 2009;37:114-24.
10. Strauss T, Lubetsky A, Ravid B, Bashari D, Luboshitz J, Lalezari S, et al. Recombinant factor concentrates may increase inhibitor development: a single centre cohort study. Haemophilia. 2011;17:625-9.
11. Hay CR. Why do inhibitors arise in patients with haemophilia A? Br J Haematol. 1999;105:584-90.
12. Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn. 2005;7:317-26.
13. Konagaya M, Takayanagi T, Kamiya T, Takamatsu S. Genetic linkage study of Duchenne muscular dystrophy and hemophilia A. Neurology. 1982;32:1046-9.
14. Gokce M, Gumruk F, Haliloglu G, Serdaroglu E, Caglayan H. Double trouble: Duchenne muscular dystrophy and hemophilia. Pediatr Blood Cancer. 2013;60:525.